col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Ovid: Current Opinion in Pulmonary Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―27 Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic Pedro A. Lamothe, Violeta Capric, F. Eun-Hyung Lee
2 [GO] 2023―May―09 Home monitoring of coronavirus disease 2019 patients in different phases of disease Kalle Majoor, Adriane D.M. Vorselaars
3 [GO] 2023―May―03 Current challenges and perspectives in lung cancer care during COVID-19 waves Domenica Francesca Mariniello, Luigi Aronne, Maria Vitale, Angela Schiattarella, Raffaella Pagliaro, Klara Komici
4 [GO] 2023―Mar―17 The association of preexisting severe asthma with COVID-19 outcomes Paul D. Terry, R. Eric Heidel, Rajiv Dhand
5 [GO] 2023―Mar―14 Drug treatment of COVID-19 infection Grace Lui, Giovanni Guaraldi
6 [GO] 2023―Mar―14 The prevalence of childhood asthma: interpreting falling rates in the context of shifting measurement and the COVID-19 pandemic Sean M. Frey, Regina K. Rowe, Jill S. Halterman
7 [GO] 2023―Mar―06 Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown David S.C. Hui, Alimuddin Zumla
8 [GO] 2023―Mar―03 Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2 Julian W. Tang, Linsey C. Marr, Raymond Tellier, Stephanie J. Dancer
9 [GO] 2023―Mar―01 Nonpharmaceutical interventions for managing SARS-CoV-2 Caitriona Murphy, Jessica Y. Wong, Benjamin J. Cowling
10 [GO] 2023―Feb―24 Effectiveness and safety of coronavirus disease 2019 vaccines Ting Shi, Chris Robertson, Aziz Sheikh
11 [GO] 2022―Aug―08 Interstitial lung disease following coronavirus disease 2019 Eirini Vasarmidi, Mada Ghanem, Bruno Crestani
12 [GO] 2022―May―12 Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges Alimuddin Zumla, David S.C. Hui
13 [GO] 2022―Mar―10 Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019 David S.C. Hui, Alimuddin Zumla
14 [GO] 2022―Feb―01 COVID-19 and other respiratory tract infections at mass gathering religious and sporting events Jaffar A. Al-Tawfiq, Sherif A. El-Kafrawy, Brian McCloskey, Esam I. Azhar
15 [GO] 2021―Dec―21 COPD in the COVID-19 era, challenging concepts and developments in COPD, and occupational exposures and susceptibilities Manish Joshi, Basil Varkey
16 [GO] 2021―Oct―25 Chronic obstructive pulmonary disease and COVID-19 Dave Singh, Alexander G. Mathioudakis, Andrew Higham
17 [GO] 2021―Oct―17 Obstructive lung diseases burden and COVID-19 in developing countries Ashutosh N. Aggarwal, Kuruswamy Thurai Prasad, Valliappan Muthu
18 [GO] 2021―Aug―25 COVID-19 outcomes in people with cystic fibrosis Pierre-Régis Burgel, Christopher Goss
19 [GO] 2021―Aug―25 Sleep medicine and coronavirus disease 2019 Cara M. Gill, Laura M. Piggott, Brian D. Kent
20 [GO] 2021―Jul―15 COVID-19 infection in patients with sarcoidosis Vivienne Kahlmann, Michael Manansala, Catharina C. Moor, Shiva Shahrara, Marlies S. Wijsenbeek, Nadera Sweiss
21 [GO] 2021―May―31 Editorial: COVID pandemic and Lung cancer: challenges lead to opportunities David E. Ost, Sneh Chauhan, Lisa Ramdhanie, Alan Fein
22 [GO] 2021―Mar―29 Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges Michael S. Niederman, Alimuddin Zumla
23 [GO] 2021―Mar―04 Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome David S. Hui, Alimuddin Zumla, Julian W. Tang
24 [GO] 2021―Mar―03 COVID-19 new diagnostics development Jim F. Huggett, Jacob Moran-Gilad, J. Eugene Lee
25 [GO] 2021―Mar―03 Management of immunosuppressants in the era of coronavirus disease-2019 Michael Manansala, Robert Baughman, Richard Novak, Marc Judson, Nadera Sweiss
26 [GO] 2021―Feb―27 Host-directed therapies for COVID-19 Markus Maeurer, Renata Ramalho, Fu-Sheng Wang, Alimuddin Zumla
27 [GO] 2021―Feb―27 COVID-19 - pathogenesis and immunological findings across the clinical manifestation spectrum Rita Carsetti, Isabella Quinti, Franco Locatelli
28 [GO] 2021―Feb―27 Coronavirus disease 2019 management Kevin C. Wilson
29 [GO] 2021―Feb―21 The role of computed tomography scan in the diagnosis of COVID-19 pneumonia Ariana Axiaq, Ahmad Almohtadi, Samuel A. Massias, Dorette Ngemoh, Amer Harky
30 [GO] 2021―Jan―20 Palliative care considerations and ethical issues in the care of Covid-19 patients Basil Varkey
31 [GO] 2021―Jan―13 COVID-19 Rajen N. Naidoo, Mohamed F. Jeebhay
32 [GO] 2021―Jan―05 Pulmonary pathology of COVID-19 Alain C. Borczuk
33 [GO] 2020―Dec―28 A trio of articles on Covid-19, followed by articles on vaping, hypersensitivity pneumonitis, and several on obstructive airway and pulmonary diseases Manish Joshi, Basil Varkey
34 [GO] 2020―Dec―17 ICU preparedness in pandemics Gavin Harris, Amesh Adalja
35 [GO] 2020―Oct―26 Dealing with asthma during the turbulent times of coronavirus disease-2019 Zuzana Diamant, Nicola A. Hanania
36 [GO] 2020―Oct―16 Asthma and severe acute respiratory syndrome coronavirus 2019 Sara M. Assaf, Svitlana P. Tarasevych, Zuzana Diamant, Nicola A. Hanania
37 [GO] 2020―Mar―05 The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security Alimuddin Zumla, Michael S. Niederman
 [1] 

37 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec